You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! Today, a look at FDA’s final guidance on drug-related apps and what it means for the future of digital therapeutics. Plus the latest in Katie’s reporting on marketing drugs over telehealth. Continue to STAT+ to read the full story…
CryptoAlerta — análise de criptomoedas e mercado em tempo real